Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Depressive Disorder, Major 2 Depression 2 Breast Neoplasms 2 Polycystic Ovary Syndrome 1 Multiple Endocrine Neoplasia Type 1 1 Emotional Regulation 1 Alcoholism 1

Interventions

Metformin 149 Clomiphene 51 Letrozole 39 Inositol 35 Folic Acid 18 Exercise 17 Progesterone 15 Ethinyl Estradiol 13 Chorionic Gonadotropin 13 Caloric Restriction 13 drospirenone and ethinyl estradiol combination 12 Estradiol 12 Contraceptives, Oral 11 cetrorelix 10 Pioglitazone 10 High-Intensity Interval Training 10 Tablets 9 Spironolactone 9 Cholecalciferol 9 Triptorelin Pamoate 8 Diet 8 Vitamin D 7 Thioctic Acid 7 Menotropins 7 Liraglutide 7 Acupuncture Therapy 7 drospirenone 6 Ovidrel 6 Gonadotropins 6 Flutamide 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Polycystic Ovary Syndrome × Interpersonal Psychotherapy × Clear all

NCT06056453 2023-09-28

IPAP

University of Colorado, Denver

Phase NA Completed

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡